Management of Acute Blood Pressure Elevation

Introduction to Hypertensive Emergencies

The European Society of Cardiology recommends labetalol or nicardipine as first-line agents for most hypertensive emergencies requiring immediate IV treatment, as they are widely available, effective, and recommended across multiple guidelines 1, 2, 3
Hypertensive emergency is defined as severe BP elevation (>180/120 mmHg) WITH acute target organ damage (encephalopathy, stroke, acute heart failure, aortic dissection, acute coronary syndrome) requiring immediate IV therapy 1, 2

Labetalol dosing is 0.25-0.5 mg/kg IV bolus OR 2-4 mg/min continuous infusion until goal BP reached, then 5-20 mg/h, with an onset of 5-10 minutes and duration of 3-6 hours 1
Nicardipine dosing starts at 5 mg/h IV infusion, increased every 15 minutes by 2.5 mg/h to a maximum of 15 mg/h, with an onset of 5-15 minutes and duration of 30-40 minutes 1, 6
The American College of Cardiology suggests that nicardipine may be superior to labetalol for achieving short-term BP targets, and is preferred in patients with contraindications to beta-blockers 3

For acute aortic dissection, the first-line treatment is esmolol (beta-blocker) PLUS nitroprusside or clevidipine, with a goal of systolic BP <120 mmHg AND heart rate <60 bpm within 20 minutes 1, 2, 3
For acute coronary syndrome/myocardial ischemia, the first-line treatment is nitroglycerin (5-200 mcg/min IV), with alternatives being urapidil or labetalol 1, 2, 6
For acute cardiogenic pulmonary edema, the first-line treatment is nitroprusside (0.3-10 mcg/kg/min) OR nitroglycerin PLUS loop diuretic, with the rationale being to optimize preload and decrease afterload 1, 2, 3

The general rule is to reduce MAP by 20-25% within the first hour, then aim for 160/100 mmHg over the next 2-6 hours 2, 4, 5
For aortic dissection, the goal is systolic BP <120 mmHg within 20 minutes 1, 2
For pulmonary edema, the goal is systolic BP <140 mmHg immediately 1, 2

Sodium nitroprusside carries significant risk of cyanide toxicity, especially with prolonged use or in renal/hepatic failure, and should only be used when other agents are unavailable or ineffective 1
Hydralazine is not first-line due to unpredictable response and adverse effects, but is acceptable for eclampsia/preeclampsia 1, 3

Overly rapid BP reduction can cause stroke, myocardial infarction, or renal failure, with large reductions exceeding 50% decrease in MAP associated with ischemic stroke and death 2
Using oral agents for true emergencies delays appropriate treatment, and treating asymptomatic severe hypertension as an emergency leads to unnecessary aggressive treatment 4, 5
Forgetting contraindications, such as asthma/COPD, heart block, or heart failure, before using labetalol is a critical pitfall to avoid 1, 6